Test to Classify Metastasis Risk in Prostate Cancers Validated by Study, GenomeDx Reports
News
GenomeDx Biosciences has announced the publication of a validation study of its Decipher Prostate Cancer Classifier, a genomic test for prostate cancer (PC) designed to improve clinical decisions regarding patient treatment and risk of metastasis ... Read more